Novel lincRNA Susceptibility Gene and Its Role in Etiopathogenesis of Thyrotoxic Periodic Paralysis

Autor(es)

Melo, Maria Clara C. ^[1] ; de Souza, Janaina S. ^[2] ; Kizys, Marina M. L. ^[1] ; Vidi, Angela C. ^[3] ; Dorta, Haron S. ^[1] ; Kunii, Ilda S. ^[1] ; Giannocco, Gisele ^[3] ; Carvalheira, Gianna ^[4] ; Dias-da-Silva, Magnus R. ^{[1, 2]}

Afiliação do(s) autor(es)

^[1] Univ Fed Sao Paulo, Lab Mol & Translat Endocrinol, Dept Med, BR-04039032 Sao Paulo - Brazil

^[2] Univ Fed Sao Paulo, Biol Sci, BR-09972270 Diadema - Brazil

^[3] Univ Fed Sao Paulo, Mol Biol Program, BR-04044020 Sao Paulo - Brazil

^[4] Univ Fed Sao Paulo, Morphol & Genet, BR-04039032 Sao Paulo - Brazil

• Tipo de documento: Artigo Científico
• Fonte: JOURNAL OF THE ENDOCRINE SOCIETY; v. 1, n. 7, p. 809-815, JUL 1 2017.
• Citações Web of Science: 0

Resumo

Thyrotoxic periodic paralysis (TPP) is a life-threatening neuromuscular complication of thyrotoxicosis characterized by muscle weakness and hypokalemia and with an unclear etiopathogenesis. However, the 17q24.3 locus had been genetically linked to TPP, in which the genetic variant rs312691 (TC genotype) in long intergenic noncoding RNA (lincRNA) CTD-2378E21.1 is located downstream of inward-rectifier potassium (Kir) channel genes {[}KCNJ2 and its antisense KCNJ2 (AS-KCNJ2)]. A TPP patient with a suppressed thyroid-stimulating hormone level, a high free thyroxine level of (5.8 ng/dL), and low serum potassium level of (2 mEq/L) was evaluated for Kir channel expression during and after recovery from thyrotoxicosis. We observed that circulating lincRNA and Kir expression varied in accordance with thyroid status and TC genotype. To endorse this association of a lincRNA-rs312691 variant with a genetic risk of TPP, an additional series of 37 patients with TPP and 32 patients with thyrotoxic without paralysis (TWP) were assessed. Weverified that the risk of minor allele Cwas greater in TPP than inTWP(odds ratio, 5.289; P = 0.0062), and protective major allele T was more frequent than observed in the 1000 genome controls (odds ratio, 11.90; P < 0.0001). AS-KCNJ2 was downregulated during thyrotoxicosis in theTWPcontrols carrying allele T and were upregulated in those with TPP with risk allele C. Moreover, KCNJ2 (Kir2.1) expression was reduced during thyrotoxicosis and restored in euthyroid status. We further excluded any other coding variant by performing targeted exome sequencing mutational screening in 17q24.3. Our data suggest that high lincRNA AS-KCNJ2 and CDT-2378E21.1 expression, possibly driven by the triiodothyronine regulatory mechanism, reduces the Kir2.1 expression observed during thyrotoxicosis. This finding could contribute to the understanding of the reduced inward-rectifying current observed during muscle weakness in genetically susceptible TPP patients. Copyright (c) 2017 Endocrine Society (AU)

• Processo FAPESP: 11/20747-8 - Investigação clínica, bioquímica e molecular da paralisia periódica tirotóxica
• Beneficiário: Magnus Régios Dias da Silva
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 09/50575-4 - Desenvolvimento de um modelo de tumorigênese in vivo para o Carcinoma Medular de Tiroide através da técnica de transgênese somática em embrião de galinha
• Beneficiário: Susan Chow Lindsey
• Modalidade de apoio: Bolsas no Brasil - Doutorado Direto
• Processo FAPESP: 12/01628-0 - Disgenesias tiroidianas: análise molecular e estudo funcional de mutações em genes candidatos a partir do sequenciamento de última geração numa coorte de 268 casos
• Beneficiário: Marina Malta Letro Kizys Polisel
• Modalidade de apoio: Bolsas no Brasil - Doutorado Direto